Andrew P. Kanarek joined OrbiMed in 1998 to focus on equity trading and operations. Previously, he was a research associate at Mehta and Isaly. Mr. Kanarek completed a B.S. in Chemistry from New York University and a B.E. in Chemical Engineering from Stevens Institute of Technology.